Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000300771 | SCV000330617 | likely pathogenic | not provided | 2019-09-05 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001381378 | SCV001579748 | pathogenic | Chédiak-Higashi syndrome | 2024-03-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3449*) in the LYST gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LYST are known to be pathogenic (PMID: 9215679, 11857544). This variant is present in population databases (rs754616030, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with LYST-related conditions. ClinVar contains an entry for this variant (Variation ID: 280681). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001381378 | SCV004191160 | likely pathogenic | Chédiak-Higashi syndrome | 2023-12-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001381378 | SCV005642595 | likely pathogenic | Chédiak-Higashi syndrome | 2024-02-15 | criteria provided, single submitter | clinical testing |